Literature DB >> 15076152

High prevalence and poor control of hypertension in primary care: cross-sectional study.

Arya M Sharma1, Hans-Ulrich Wittchen, Wilhelm Kirch, David Pittrow, Eberhard Ritz, Burkhard Göke, Hendrik Lehnert, Diethelm Tschöpe, Petra Krause, Michael Höfler, Hildegard Pfister, Peter Bramlage, Thomas Unger.   

Abstract

OBJECTIVE: To report: (1) on the background, design and methods of the Hypertension and Diabetes Risk Screening and Awareness (HYDRA) study, (2) on the point prevalence of hypertension in primary care and (3) on the proportion of treated, controlled, and uncontrolled hypertension.
DESIGN: Cross-sectional point prevalence study.
SETTING: Representative nationwide sample of 1912 primary care practices in Germany. PARTICIPANTS: A total of 45,125 unselected primary care attendees. MAIN OUTCOME MEASURES: Prevalence of hypertension based on doctor's diagnosis, self-reported diagnosis, and blood pressure (BP) measurements.
RESULTS: A total of 39% of all patients and 67% of patients aged 60 years or older, respectively, were diagnosed by their doctors as having hypertension. Eighty-four percent of diagnosed patients were on antihypertensive medication, 57% of which were rated by the physician as well controlled. When hypertension was defined as either current BP levels > or = 140/90 mmHg and/or current antihypertensive medication, the total point prevalence increased to 50%, while treatment and control rates (BP < 140/90 mmHg) dropped to 64 and 19%, respectively.
CONCLUSIONS: Extrapolation of these findings to the entire primary care patient population seen in the over 20 000 primary care practices in Germany suggests that on an average day, over 700,000 patients with elevated BP are seen by primary care physicians, but that only around 132,000 of these patients are well controlled. Thus, this study not only documents the enormous burden of hypertensive patients in the primary health system, but also highlights the alarming lack of BP control in the vast majority of hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076152     DOI: 10.1097/00004872-200403000-00009

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  40 in total

1.  Prescribing pattern of antihypertensive drugs in primary care units in Turkey: results from the TURKSAHA study.

Authors:  Adnan Abaci; Omer Kozan; Aytekin Oguz; Mahmut Sahin; Necmi Deger; Huseyin Senocak; Nizamettin Toprak; Haydar Sur; Cetin Erol
Journal:  Eur J Clin Pharmacol       Date:  2007-04       Impact factor: 2.953

2.  Blood pressure management in a cohort of hypertensive patients in Germany treated by cardiologists.

Authors:  Martin Thoenes; Ulrich Tebbe; Ludger Rosin; W Dieter Paar; Peter Bramlage; Wilhelm Kirch; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2011-01-05       Impact factor: 5.460

3.  Managing hypertension among nursing-home residents and community-dwelling elderly in Germany: a comparative pharmacoepidemiological study.

Authors:  Sophie Lochner; Wilhelm Kirch; Christoph Schindler
Journal:  Eur J Clin Pharmacol       Date:  2011-12-30       Impact factor: 2.953

Review 4.  Apparent and true resistant hypertension: definition, prevalence and outcomes.

Authors:  E Judd; D A Calhoun
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

Review 5.  Can we justify goal blood pressure of <140/90 mm Hg in most hypertensives?

Authors:  Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

Review 6.  Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection.

Authors:  Domenico Galzerano; Cristina Capogrosso; Sara Di Michele; Emanuele Bobbio; Paola Paparello; Carlo Gaudio
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

7.  Cardiovascular risk in obese hypertensive patients taking various antihypertensive drugs.

Authors:  Christoph Schindler; Peter Bramlage; Martin Thoenes; Carsten Bramlage; Wilhelm Kirch
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

8.  Secular Trends in Prescription Patterns of Single-Pill Combinations of an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Plus a Thiazide Diuretic for Hypertensive Patients in Taiwan.

Authors:  Chih-Neng Hsu; Tzung-Dau Wang
Journal:  Acta Cardiol Sin       Date:  2013-01       Impact factor: 2.672

9.  BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartan.

Authors:  Joachim Schrader; Peter Bramlage; Stephan Lüders; Martin Thoenes; Andreas Schirmer; Dieter W Paar
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

10.  Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: a prospective observational study.

Authors:  Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Matthias Kröz; Angelina Bockelbrink; Claudia M Witt; Stefan N Willich; Harald Matthes
Journal:  BMC Fam Pract       Date:  2009-12-10       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.